Evidence map›Paper›PMID 30227144›Full record

ArticleMetabolism: clinical and experimental2018

Limitations of platform assays to measure serum 25OHD level impact on guidelines and practice decision making.

Maya Rahme, Laila Al-Shaar, Ravinder Singh, Rafic Baddoura, Georges Halaby, Asma Arabi, Robert H Habib, Rose Daher, Darina Bassil, Karim El-Ferkh and 2 more

Abstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Optimisation of vitamin D status in global populations.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Review
  6. Vitamin D Measurement: Clinical Practice and Research Implications.The journal for nurse practitioners : JNP · 2023
    Article
  7. Article
  8. Article
  9. Vitamin D testing: advantages and limits of the current assays.European journal of clinical nutrition · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Maya RahmeDepartment of Internal Medicine, Division of Endocrinology, Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut, Lebanon.
Laila Al-ShaarDepartment of Internal Medicine, Division of Endocrinology, Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut, Lebanon.
Ravinder SinghDivision of Clinical Biochemistry and Immunology, Mayo Clinic Laboratories, Mayo Clinic, Rochester, MN, USA.
Rafic BaddouraDepartment of Rheumatology, Hotel Dieu de France, St Joseph University, Beirut, Lebanon.
Georges HalabyDepartment of Endocrinology, Hotel Dieu de France, St Joseph University, Beirut, Lebanon.
Asma ArabiDepartment of Internal Medicine, Division of Endocrinology, Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut, Lebanon.
Robert H HabibDepartment of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Rose DaherDepartment of Pathology & Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Darina BassilDepartment of Internal Medicine, Division of Endocrinology, Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut, Lebanon.
Karim El-FerkhDepartment of Internal Medicine, Division of Endocrinology, Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut, Lebanon.
Maha HoteitDepartment of Internal Medicine, Division of Endocrinology, Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut, Lebanon.
Ghada El-Hajj FuleihanDepartment of Internal Medicine, Division of Endocrinology, Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: gf01@aub.edu.lb.
American University of Beirut Medical Center · LBSaint Joseph University · LBMayo Clinic · US

Funding

Genetic and Metabolic Determinants of 25(OH)D levels at Baseline and One Year: Findings from a Dose Ranging Vitamin D trialD43TW009118 · FIC · AMERICAN UNIVERSITY OF BEIRUT · PI FULEIHAN, GHADA ELHAJJ · 2012 to 2024
$2.5M
FIC NIH HHS D43 TW009118
6 · The paper itself

Abstract

contextLiquid Chromatography Mass Spectroscopy (LC-MS/MS) is the preferred method to measure 25 hydroxyvitamin D (25OHD) levels, but laboratories are increasingly adopting automated platform assays.

objectiveWe assessed the performance of commonly used automated immunoassays, with that of LC-MS/MS, and the National Institute of Standards and Technology (NIST) reference values, to measure 25OHD levels. METHODS/

settingWe compared serum 25OHD levels obtained from 219 elderly subjects, enrolled in a vitamin D trial, using the Diasorin Liaison platform assay, and the tandem LC-MS/MS method. We also assessed the performance of the Diasorin and Roche automated assays, expressed as mean % bias from the NIST standards, based on the vitamin D External Quality Assessment Scheme (DEQAS) reports, from 2013 to 2017.

resultsSerum 25OHD levels were significantly lower in the Diasorin compared to LC-MS/MS assay at baseline, 18.5 ± 7.8 vs 20.5 ± 7.6 ng/ml (p < 0.001), and all other time points. Diasorin (25OHD) = 0.76 × LC-MS/MS (25OHD) + 4.3, R

conclusionThe performance of most widely used automated assays is sub-optimal. Our findings underscore the pressing need to re-consider current practices with regard to 25OHD measurements, interpretation of results from research studies, meta-analyses, the development of vitamin D guidelines, and their relevance to optimizing health.

Indexed as

Clinical Decision-MakingAgedAutomationChromatography, High Pressure LiquidFemaleGuidelines as TopicHumansImmunoassayLuminescenceMaleMass SpectrometryNutritional StatusOverweightReference ValuesReproducibility of ResultsVitamin D25-hydroxyvitamin DVitamin D

Identifiers

PMID30227144
PMCPMC6258831
OpenAlexW2889576061

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.